JulesHBlankMD

PubMed

• 11 citations
  VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study.
  Julie E. Chang, Lakeesha Carmichael, KyungMann Kim, Christopher Peterson, David T. Yang, Anne M. Traynor, Jae Werndli, Michael S. Huie, Thomas McFarland, Michael Volk,...> ;Clinical Lymphoma, Myeloma & Leukemia. 2018 Jan 1
• 16 citations
  Targeting Estrogen Receptor Beta in a Phase 2 Study of High-Dose Estradiol in Metastatic Triple-Negative Breast Cancer: A Wisconsin Oncology Network Study
  Kari B. Wisinski, Wei Xu, Amye J. Tevaarwerk, Sandeep Saha, KyungMann Kim, Anne M. Traynor, Leah L. Dietrich, Robert Hegeman, Dhimant Patel, Jules H. Blank, Josephine ...> ;Clinical Breast Cancer. 2016 Aug 1
• 11 citations
  Bendamustine + rituximab chemoimmunotherapy and maintenance lenalidomide in relapsed, refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma: A Wiscon...
  Julie E. Chang, Thomas C. Havighurst, KyungMann Kim, Jens C. Eickhoff, Anne M. Traynor, Rachel Kirby-Slimp, Lynn M. Volk, Jae Werndli, Ronald S. Go, Matthias Weiss, Ju...> ;British Journal of Haematology. 2016 Feb 23
• 34 citations
  A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study
  Timothy S. Fenske, Namrata Shah, Kyung Mann Kim, Sandeep Saha, Chong Zhang, Arielle Baim, John P. Farnen, Adedayo A. Onitilo, Jules H. Blank, Harish Ahuja, Tim Wassena...> ;Cancer. 2015 Oct 1
• 29 citations
  Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study
  Tien Hoang, Toby C. Campbell, Chong Zhang, KyungMann Kim, Jill M. Kolesar, Kurt R. Oettel, Jules H. Blank, Emily Robinson, Harish Ahuja, Ron J. Kirschling, Peter H. Jo...> ;Investigational New Drugs. 2014 Feb 1
• 44 citations
  VcR-CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study
  Julie E. Chang, Christopher Peterson, Sangbum Choi, Jens C. Eickhoff, KyungMann Kim, David T. Yang, Leslie A. Gilbert, Eric S. Rogers, Jae Werndli, Michael S. Huie, Th...> ;British Journal of Haematology. 2011 Oct 1
• 34 citations
  Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology Network
  Vaishalee P. Kenkre, Walter L Long, Jens C. Eickhoff, Jules H. Blank, Thomas McFarland, Wayne A. Bottner, Hamied Rezazedeh, Jae Werndli, Howard H. Bailey, Brad S. Kahl> ;Leukemia & Lymphoma. 2011 Aug 24
• Vorinostat (V) and bortezomib (B) as third-line treatment in patients with advanced non-small cell lung cancer (NSCLC): A Wisconsin Oncology Network Phase II Study.
  Jones MW, Zhang C, Oettel KR, Blank JH, Robinson EG, Ahuja HG, Kirschling RJ, Johnson PH, Huie MS, Kolesar J, Wims MB, Hernan H, Campbell TC, Traynor AM, Hoang T> ;J. Clin. Oncol.. 2011-05-20
• Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology Network.
  Kenkre, V.P., Long, W.L., Eickhoff, J.C., Blank, J.H., McFarland, T.A., Bottner, W., Rezazedeh, H., Werndli, J.E., Bailey, H.H., Kahl, B.S.> ;Leuk Lymphoma. 2011-05-17
• 44 citations
  Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer
  Steven Attia, Jens C. Eickhoff, George Wilding, Douglas G. McNeel, Jules H. Blank, Harish Ahuja, Alcee Jumonville, Michael Eastman, Daniel H. Shevrin, Michael Glode, D...> ;Clinical Cancer Research. 2008 Apr 15
• 90 citations
  Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology N...
  Brad S. Kahl, Walter L. Longo, Jens C. Eickhoff, James L. Zehnder, Carol D. Jones, Jules H. Blank, Thomas McFarland, Wayne A. Bottner, H. Rezazedeh, Jae Werndli, Howar...> ;Annals of Oncology. 2006 Sep 1
• Join now to see all